Cargando…
Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease characterized by sustained increase in the pulmonary arterial pressure and excessive thickening and remodeling of the distal small pulmonary arteries. During disease progression, structural remodeling of the right ventricul...
Autores principales: | Lee, Jae Chul, Kim, Kwan Chang, Choe, Soo Young, Hong, Young Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Anatomists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819080/ https://www.ncbi.nlm.nih.gov/pubmed/27051563 http://dx.doi.org/10.5115/acb.2016.49.1.7 |
Ejemplares similares
-
Localization of Brain Natriuretic Peptide Immunoreactivity in Rat Spinal Cord
por: Abdelalim, Essam M., et al.
Publicado: (2016) -
Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats
por: Lee, Jae Chul, et al.
Publicado: (2014) -
C-Type Natriuretic Peptide Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction in Rats with Pulmonary Arterial Hypertension
por: Gao, Xiaowei, et al.
Publicado: (2018) -
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
por: Casserly, Brian, et al.
Publicado: (2009) -
Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
por: Lee, Jae Chul, et al.
Publicado: (2015)